CX3CL1 enhanced NSCLC cell transendothelial migration by increasing permeability of VBMECs via ICAM-1-dependent activation of the Src/GEF-H1 pathway. The gene discussed is ARHGEF2; the disease is non-small cell lung carcinoma.